RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+18.85%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.59B
AUM Growth
+$2.59B
(+13%)
Cap. Flow
+$99.8M
Cap. Flow
% of AUM
3.85%
Top 10 Holdings %
Top 10 Hldgs %
46.26%
Holding
80
New
11
Increased
26
Reduced
24
Closed
16
Top Buys
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$78.7M |
| 2 |
Xencor
XNCR
|
$55.6M |
| 3 |
Atara Biotherapeutics
ATRA
|
$55.4M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$45.1M |
| 5 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$38.3M |
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$89.8M |
| 2 |
AstraZeneca
AZN
|
$70.1M |
| 3 |
CELG
Celgene Corp
CELG
|
$68.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$61.8M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$34.2M |
Sector Composition
| 1 | Healthcare | 92.32% |
| 2 | Financials | 0.74% |
| 3 | Communication Services | 0.37% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
26
DELISTED
Cymabay Therapeutics
CBAY
| $38.4M | 1.48% | 2,955,565 +953,300 | +48% | +$12.4M |
|
|
CBIO
27
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
| $37M | 1.43% | 2,282,268 +351,600 | +18% | +$5.71M |
|
|
EPZM
28
DELISTED
Epizyme, Inc
EPZM
| $35.7M | 1.38% | 2,011,989 +86,300 | +4% | +$1.53M |
|
29
UnitedHealth
UNH
$281B
| $31.1M | 1.2% | 145,420 -3,200 | -2% | -$685K |
|
|
OXFD
30
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $30.7M | 1.19% | 2,469,687 +151,300 | +7% | +$1.88M |
|
|
JNCE
31
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $26.4M | 1.02% | 1,182,393 +202,000 | +21% | +$4.51M |
|
|
NITE
32
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $25.4M | 0.98% | 1,768,946 -3,900 | -0.2% | -$56K |
|
|
ELGX
33
DELISTED
Endologix Inc
ELGX
| $25.1M | 0.97% | 5,923,161 -4,940 | -0.1% | -$20.9K |
|
34
InflaRx
IFRX
$108M
| $24.5M | 0.95% | 851,100 -6,200 | -0.7% | -$179K |
|
|
SYRS
35
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $21.4M | 0.83% | 1,652,240 +1,015,008 | +159% | +$13.2M |
|
|
PRAH
36
DELISTED
PRA Health Sciences, Inc.
PRAH
| $20.4M | 0.79% | 245,314 -5,300 | -2% | -$440K |
|
|
MDRX
37
DELISTED
Veradigm Inc. Common Stock
MDRX
| $20.1M | 0.78% | 1,626,900 -143,700 | -8% | -$1.77M |
|
|
CMRX
38
DELISTED
Chimerix, Inc.
CMRX
| $19.4M | 0.75% | 3,728,690 -104,088 | -3% | -$541K |
|
39
argenx
ARGX
$43.6B
| $19.2M | 0.74% | 238,600 +38,600 | +19% | +$3.1M |
|
40
eHealth
EHTH
$118M
| $19M | 0.74% | 1,330,495 -228,419 | -15% | -$3.27M |
|
|
HSKA
41
DELISTED
Heska Corp
HSKA
| $18.9M | 0.73% | 238,446 +42,050 | +21% | +$3.32M |
|
|
DCPH
42
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $16.5M | 0.64% | 821,280 +137,400 | +20% | +$2.75M |
|
43
Viatris
VTRS
$12.3B
| $15.7M | 0.61% | +381,000 | New | +$15.7M |
|
|
LUMO
44
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $14.9M | 0.58% | 2,054,200 -42,290 | -2% | -$307K |
|
|
ODT
45
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $12.6M | 0.49% | 594,200 -2,700 | -0.5% | -$57.2K |
|
|
ARMO
46
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
| $11.2M | 0.43% | +298,800 | New | +$11.2M |
|
47
Teladoc Health
TDOC
$1.37B
| $11M | 0.43% | 273,200 +123,200 | +82% | +$4.96M |
|
|
NVTA
48
DELISTED
Invitae Corporation
NVTA
| $10M | 0.39% | 2,139,520 -82,520 | -4% | -$387K |
|
49
CytomX Therapeutics
CTMX
$336M
| $9.52M | 0.37% | 334,680 -84,000 | -20% | -$2.39M |
|
|
MODN
50
DELISTED
MODEL N, INC.
MODN
| $9.46M | 0.37% | 523,937 -329,777 | -39% | -$5.95M |
|